FDA recalls high blood pressure, heart failure medication due to cancer risk

Ministry of Health recalls medicines containing chemical suspected to cause cancer - Oman

Ministry of Health recalls medicines containing chemical suspected to cause cancer - Oman

A spokesman for Major Pharmaceuticals said they were recalling several lots and referred other questions to Teva, which supplies valsartan that they package and sell. Solco and Teva were also asked to recall their drugs containing valsartan/hydrochlorothiazide (HCTZ).

The EMA said on July 5 that an investigation into valsartan, an ingredient in medication used to treat high blood pressure, showed the drugs made by Huahai contained a carcinogen named N-nitrosodimethylamine, or NDMA.

The FDA is now looking into the potential impacts the drugs have had on patients who have already taken them, as well as how to get rid of the impurity from future batches of these products.

Instead, they should to continue taking the drugs until a replacement is found and should contact their health care professional, the FDA advised, according to Time. He said the importers of the Zhejiang Huahai-supplied valsartan included Karachi's Amarant Pharmaceuticals, Efroze Chemical Industries, High-Q Pharmaceuticals, Pharm-Evo, Safe Pharmaceuticals, Sami Pharmaceuticals and Tabros Pharma, and Lahore's Searle Pharmaceuticals and Genetics Pharmaceuticals.

Not all products containing valsartan are being recalled. To determine if you're medication has been recalled, look at the drug name and company name on the label of your prescription bottle.

The recall, which also includes valsartan-hydrochlorothiazide tablets, followed a similar action taken by the European Medicines Agency.

The EMA said NDMA was an unexpected impurity that was not detected by routine tests carried out by Zhejiang Huahai, adding that the manufacturing changes introduced in 2012 were believed to have produced NDMA as a by-product.

You can find more information about the recall here.

Islamabad:The drug regulator has ordered the immediate recall of some heart medicines for containing a potentially cancer-causing chemical.

The FDA has said it will "continue to investigate this issue and provide additional information when it becomes available". "Not all the products are recalled, just certain manufacturers".

The FDA previously reported that imported medications and their ingredients may not have been evaluated for safety and effectiveness in the US, even if they were legal in foreign countries.

Overall, more than two-thirds of all active drug ingredients originate in China and India, industry experts estimate, with China accounting for the lion's share.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.